Abstract
New antimicrobial drugs for treatment of complicated urinary tract infection (cUTI) are generally assessed in randomized, double-blind, noninferiority clinical trials. Robust historical data for the active comparator inform on treatment effect estimation, yet typically do not substitute for the active comparator data in the proposed trial. We report design options for a phase 3 trial of cUTI using a Bayesian hierarchical model and historical data from 2 well-executed phase 3 registrational trials of doripenem. The methodology is directly applicable to other phase 3 noninferiority settings. In addition to the research design application, we provide a novel methodology for assessing the robustness of type I error control. The model borrows heavily from the prior data when the current active comparator parameter estimate approximated the historical estimate. In contrast, the model had restricted borrowing when the 2 estimates were very different. The alternative trial design, with or without the inclusion of futility stopping criteria, provides a framework for future cUTI phase 3 trials.
References
Mar 1, 1976·Journal of Chronic Diseases·S J Pocock
Mar 1, 1990·Statistics in Medicine·P F Thall, R Simon
Mar 1, 1987·Controlled Clinical Trials·B W BrownM E Rozell
Apr 1, 1985·Statistics in Medicine·O Miettinen, M Nurminen
Dec 30, 1996·Statistics in Medicine·J P Higgins, A Whitehead
Nov 12, 2005·Clinical Trials : Journal of the Society for Clinical Trials·Steven N Goodman, John T Sladky
Sep 4, 2007·Biometrics·Satoshi MoritaPeter Müller
Apr 22, 2008·International Journal of Epidemiology·Nikolaos A PatsopoulosJohn P A Ioannidis
Jul 8, 2009·Antimicrobial Agents and Chemotherapy·K G NaberR Redman
Feb 17, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Beat NeuenschwanderDavid J Spiegelhalter
Feb 10, 2011·Journal of Chemotherapy·R RedmanK G Naber
Nov 4, 2011·Clinical Trials : Journal of the Society for Clinical Trials·Jesse A Berlin, M Soledad Cepeda
Jul 27, 2012·Current Opinion in Pharmacology·David M Shlaes, Brad Spellberg
Aug 15, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·UNKNOWN Infectious Diseases Society of America
Nov 23, 2012·Clinical Trials : Journal of the Society for Clinical Trials·Jesse A BerlinJuergen Kuebler
Jun 1, 2013·Statistics in Medicine·Sandro GsteigerHeinz Schmidli
Aug 6, 2013·Pharmaceutical Statistics·Meg A GamaloLisa M LaVange
Aug 6, 2013·Pharmaceutical Statistics·Kert VieleLaura Thompson
Aug 14, 2013·Antimicrobial Agents and Chemotherapy·Krishan P SinghLinda M Mundy
Jun 18, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Florian M WagenlehnerLeanne B Gasink
Jul 6, 2017·The New England Journal of Medicine·Janet Woodcock, Lisa M LaVange